GlassScriptPhysician profile
Shannon Nicole Mitchell
NPI 1942943667
$3,356.69
in general payments reported to CMS, 2019-2025
18 companies · $951 in 2025
The $951 reported for 2025 was more than what 86% of Primary Care providers received nationally (typical 2025 total: $170).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $154 · 2023: $1,555 · 2024: $697 · 2025: $951.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,159 · Travel and Lodging: $541 · Consulting Fee: $350 · Education: $153.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,159.19 |
| Travel and Lodging | $540.88 |
| Consulting Fee | $350.00 |
| Education | $153.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Respicardia, INC. | $899.09 | 2023 | Remede System |
| Harmony Biosciences LLC | $548.32 | 2023-2025 | Wakix |
| Axsome Therapeutics, INC. | $448.42 | 2022-2025 | Sunosi |
| Jazz Pharmaceuticals INC. | $441.27 | 2022-2025 | |
| Avadel Cns Pharmaceuticals, LLC | $356.45 | 2024-2025 | Lumryz |
| Idorsia Pharmaceuticals US INC | $119.02 | 2023 | Quviviq |
| Pfizer INC. | $111.72 | 2024-2025 | |
| Kestra Medical Technology Services, INC. | $98.69 | 2025 | Assure Wcd |
| Inspire Medical Systems, INC. | $63.45 | 2024 | Inspire |
| Resmed Corp | $48.79 | 2024 | |
| 3b Medical, INC. | $40.32 | 2025 | Luna |
| Merck Sharp & Dohme LLC | $39.70 | 2025 | Verquvo, Capvaxive |
| Astrazeneca Pharmaceuticals LP | $38.96 | 2025 | Farxiga |
| Philips North America LLC | $27.59 | 2025 | Extended Holter |
| Bayer Healthcare Pharmaceuticals INC. | $23.15 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $19.13 | 2025 | Lifevest |
| Glaxosmithkline, LLC. | $16.79 | 2025 | Arexvy, Shingrix |
| Lilly USA, LLC | $15.83 | 2025 | Zepbound |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shannon Mitchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.